Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine Infusion for Neuropathic Pain
NCT02597257Phase 2Unknown
- Sponsor
- Seoul National University Hospital
- Start
- Aug 2015
- Primary completion
- Jul 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Lidocaine Hydrochloride Injection, without epinephrine in postherpetic neuralgia (PHN), diabetic polyneuropathy (DPN), peripheral neuropathy, sponsored by Seoul National University Hospital. Status: unknown.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postherpetic neuralgia (PHN)diabetic polyneuropathy (DPN)peripheral neuropathy
Beyond the preview
Go deeper on NCT02597257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02597257.